A Study of AK104, a PD-1/CTLA-4 Bispecific Antibody in Subjects With Recurrent/Metastatic Cervical Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Leslie Randall, MD
Virginia Commonwealth University
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
25 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Monash Health
Clayton, Victoria, Australia
- Sir Charles Gairdner Hospital
Nedlands, Western Australia, Australia
- Ashford Cancer Centre Research
Adelaide, Australia
- Blacktown Hospital
Blacktown, Australia
- Icon Cancer Centre
Brisbane, Australia
- Auckland City Hospital
Grafton, Auckland, New Zealand
- Womens Cancer Research Foundation
Newport Beach, California, United States
- Sylvester Comprehensive Cancer Center
Miami, Florida, United States
- Brcr Medical Center
Plantation, Florida, United States
- Augusta University Medical Center
Augusta, Georgia, United States
- Illinois Cancer Specialists
Arlington Heights, Illinois, United States
- Maryland Oncology Hematology (plum Orchard)
Silver Spring, Maryland, United States
- Monter Cancer Center
Lake Success, New York, United States
- the Blavatnik Family - Chelsea Medical Center at Mount Sinai
New York, New York, United States
- Oncology Hematology Care Inc
Cincinnati, Ohio, United States
- Oklahoma Cancer Specialists and Research Institute, Llc
Tulsa, Oklahoma, United States
- Chattanooga'S Program in Women'S Oncology
Chattanooga, Tennessee, United States
- Tennessee Oncology - Centennial Clinic
Nashville, Tennessee, United States
- University of Texas Southwestern
Dallas, Texas, United States
- Texas Oncology-Fort Worth Cancer Center
Fort Worth, Texas, United States
- Lyndon B. Johnson Hospital (md Anderson)
Houston, Texas, United States
- Texas Oncology (woodlands)
The Woodlands, Texas, United States
- Virginia Oncology Associates
Norfolk, Virginia, United States
- Virginia Commonwealth University
Richmond, Virginia, United States
- Pacific Gynecology Specialists, P. C.
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 Jul 2020
- Primary completion
- 22 Dec 2022
- Completion
- 31 Jan 2023
- Last update posted
- 28 Feb 2025
- Registered enrollment
- 30
- Registry id
- NCT04380805
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.